NUVASIVE INC
DelistedCIK 1142596fmd_1XFT3NW4MNRY16Z1QR5MRVFBBHManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2008 to Jun 30, 2023, 58 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 685 | – | – | 962 | 1,027 | 1,102 | 1,168 | 1,051 | 1,139 | 1,202 |
| Cost of revenue | 180 | 182 | 194 | 240 | 268 | 311 | 312 | 322 | 322 | 337 |
| Gross profit | 505 | 580 | 617 | 722 | 758 | 791 | 856 | 729 | 817 | 865 |
| Realized investment gains (losses) | – | – | – | – | – | (4) | (5) | (2) | 3 | (1) |
| Research and development | 32 | 37 | 36 | 48 | 50 | 62 | 72 | 80 | 93 | 99 |
| Selling, general and administrative | 420 | 457 | 457 | 534 | 540 | 576 | 611 | 547 | 610 | 634 |
| Total operating expenses | 472 | 562 | 478 | 598 | 647 | 736 | 733 | 691 | 829 | 777 |
| Operating income | 33 | 18 | 139 | 124 | 111 | 54 | 123 | 38 | (12) | 88 |
| Interest expense | 27 | 28 | 29 | 41 | 38 | 38 | 39 | 70 | 21 | 17 |
| Interest and investment income | 1 | 1 | 2 | 1 | 0 | 1 | 2 | 1 | 0 | 3 |
| Other non-operating income (expense) | (23) | (29) | (27) | (59) | (39) | (45) | (43) | (86) | (46) | (36) |
| Income before taxes | 10 | (11) | 112 | 65 | 72 | 9 | 81 | (48) | (58) | 52 |
| Income tax expense | 3 | 6 | 47 | 29 | (7) | (4) | 15 | (10) | 6 | 12 |
| Net income from continuing operations | 7 | (17) | 65 | 35 | 80 | 12 | 65 | (37) | (64) | 40 |
| Net income | 8 | (17) | 66 | 37 | 82 | 12 | 65 | (37) | (64) | 40 |
| Net income to common shareholders | 8 | (17) | 66 | – | – | – | – | – | – | – |